CAS 1338934-59-0

Fórmula: C18H19NO7

InChI: InChI=1S/C18H19NO7/c1-10-11-7-14(24-2)16(22)13(9-20)17(11)26-18(23)12(10)8-15(21)19-3-5-25-6-4-19/h7,9,22H,3-6,8H2,1-2H3

Clave InChI: IFDGMRMUJYGWQQ-UHFFFAOYSA-N

SMILES: CC1=C(C(=O)OC2=C(C(=C(C=C12)OC)O)C=O)CC(=O)N3CCOCC3

MKC8866

CAS: 1338934-59-0

MKC8866, a selective IRE1 RNase inhibitor with an IC50 of 0.29 μM, curbs breast and prostate cancer cell growth.

Fórmula: C₁₈H₁₉NO₇

Pureza: 99.28% - 99.91%

Forma y color: Yellow Solid

Peso molecular: 361.346

Ref: TM-T15594

MKC8866

CAS: 1338934-59-0

MKC8866

Fórmula: C₁₈H₁₉NO₇

Pureza: 99.5%

Peso molecular: 361.35

Ref: 54-BUP12551

2H-1-Benzopyran-8-carboxaldehyde, 7-hydroxy-6-methoxy-4-methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-2-oxo-

CAS: 1338934-59-0

Fórmula: C₁₈H₁₉NO₇

Pureza: 99%

Forma y color: Solid

Peso molecular: 361.3460

Ref: IN-DA01EOOW

MKC8866

CAS: 1338934-59-0

7-Hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde

Fórmula: C₁₈H₁₉NO₇

Pureza: 99%

Peso molecular: 361.35

Ref: IN-DG00961093

MKC8866

CAS: 1338934-59-0

MKC8866 is a selective antagonist that targets the metabotropic glutamate receptor 2 (mGluR2), which is a type of glutamate receptor expressed in various regions of the central nervous system (CNS). Derived from pharmacological research, this compound offers critical insights into the modulation of synaptic activity and neuronal signaling through inhibition of mGluR2.

Fórmula: C₁₈H₁₉NO₇

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 361.35 g/mol

Ref: 3D-NDC93459